You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 6, June 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reduced Corticotropin Releasing Factor Binding Sites in the Frontal Cortex of Suicide Victims

Charles B. Nemeroff, MD, PhD; Michael J. Owens; Garth Bissette, PhD; Anne C. Andorn, MD; Michael Stanley, PhD

Arch Gen Psychiatry. 1988;45(6):577-579.


Abstract

• Previous studies have provided evidence that corticotropin releasing factor (CRF) is hypersecreted in patients with major depression. This CRF hypersecretion is believed to contribute at least in part to hyperactivity of the hypothalamicpituitary-adrenal axis in depressed patients. If CRF is chronically hypersecreted in depressed patients, then, due to downregulation, a reduced number of CRF receptor binding sites should be present in patients with profound depressive disorder. To test this hypothesis, we measured the number and affinity of CRF binding sites in the frontal cortex of 26 suicide victims and 29 controls who died of a variety of causes. There was a marked (23%) reduction in the number of CRF binding sites in the frontal cortex of the suicide victims compared with the controls. These data are consistent with the hypothesis that CRF is hypersecreted in depression.



Author Affiliations

From the Departments of Psychiatry (Drs Nemeroff and Bissette) and Pharmacology (Mr Owens), Duke University Medical Center, Durham, NC; the Department of Psychiatry, Cleveland Metropolitan General Hospital, Case Western Reserve University School of Medicine (Dr Andorn); and the Departments of Psychiatry and Pharmacology, Columbia University College of Physicians & Surgeons and the New York State Psychiatric Institute, New York (Dr Stanley).


Footnotes

Accepted for publication Dec 14, 1987.

Reprint requests to Departments of Psychiatry and Pharmacology, Box 3859, Duke University Medical Center, Durham, NC 27710 (Dr Nemeroff).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Neurobiological Toll of Child Abuse and Neglect
Neigh et al.
Trauma Violence Abuse 2009;10:389-410.
ABSTRACT  

Antiglucocorticoids in psychiatry
McIsaac et al.
Adv. Psychiatr. Treat. 2009;15:242-249.
ABSTRACT | FULL TEXT  

A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH1 Antagonist) in the Treatment of Major Depression
Binneman et al.
Am. J. Psychiatry 2008;165:617-620.
ABSTRACT | FULL TEXT  

Influence of Child Abuse on Adult Depression: Moderation by the Corticotropin-Releasing Hormone Receptor Gene
Bradley et al.
Arch Gen Psychiatry 2008;65:190-200.
ABSTRACT | FULL TEXT  

Gene Expression Profiling in Postmortem Prefrontal Cortex of Major Depressive Disorder
Kang et al.
J. Neurosci. 2007;27:13329-13340.
ABSTRACT | FULL TEXT  

Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.
Kennedy et al.
Arch Gen Psychiatry 2006;63:1199-1208.
ABSTRACT | FULL TEXT  

Hypercortisolemia and Depression
Gillespie and Nemeroff
Psychosom. Med. 2005;67:S26-S28.
ABSTRACT | FULL TEXT  

Characterization of the Human Corticotropin-Releasing Factor2(a) Receptor Promoter: Regulation by Glucocorticoids and the Cyclic Adenosine 5'-Monophosphate Pathway
Nanda et al.
Endocrinology 2004;145:5605-5615.
ABSTRACT | FULL TEXT  

Deficits in Hippocampal and Anterior Cingulate Functioning During Verbal Declarative Memory Encoding in Midlife Major Depression
Bremner et al.
Am. J. Psychiatry 2004;161:637-645.
ABSTRACT | FULL TEXT  

Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAA Receptor Subunits in Frontal Cortical Brain Region
Merali et al.
J. Neurosci. 2004;24:1478-1485.
ABSTRACT | FULL TEXT  

Brain Systems Underlying Susceptibility to Helplessness and Depression
Shumake and Gonzalez-Lima
Behav Cogn Neurosci Rev 2003;2:198-221.
ABSTRACT  

Altered Gene Expression of Brain-Derived Neurotrophic Factor and Receptor Tyrosine Kinase B in Postmortem Brain of Suicide Subjects
Dwivedi et al.
Arch Gen Psychiatry 2003;60:804-815.
ABSTRACT | FULL TEXT  

Abnormal Expression and Functional Characteristics of Cyclic Adenosine Monophosphate Response Element Binding Protein in Postmortem Brain of Suicide Subjects
Dwivedi et al.
Arch Gen Psychiatry 2003;60:273-282.
ABSTRACT | FULL TEXT  

A Current Perspective of Suicide and Attempted Suicide
Mann
ANN INTERN MED 2002;136:302-311.
ABSTRACT | FULL TEXT  

Psychological Stress Increases Hippocampal Mineralocorticoid Receptor Levels: Involvement of Corticotropin-Releasing Hormone
Gesing et al.
J. Neurosci. 2001;21:4822-4829.
ABSTRACT | FULL TEXT  

The Dexamethasone Suppression Test and Suicide Prediction
Coryell and Schlesser
Am. J. Psychiatry 2001;158:748-753.
ABSTRACT | FULL TEXT  

Regulation of Serotonin Release in the Lateral Septum and Striatum by Corticotropin-Releasing Factor
Price and Lucki
J. Neurosci. 2001;21:2833-2841.
ABSTRACT | FULL TEXT  

Childhood Sexual Abuse as a Risk Factor for Depression in Women: Psychosocial and Neurobiological Correlates
Weiss et al.
Am. J. Psychiatry 1999;156:816-828.
ABSTRACT | FULL TEXT  

Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001
Okuyama et al.
J. Pharmacol. Exp. Ther. 1999;289:926-935.
ABSTRACT | FULL TEXT  

Reduced Activity of Hypothalamic Corticotropin-Releasing Hormone Neurons in Transgenic Mice with Impaired Glucocorticoid Receptor Function
Dijkstra et al.
J. Neurosci. 1998;18:3909-3918.
ABSTRACT | FULL TEXT  

Corticotrophin releasing factor--a peptide link between stress and psychopathology associated with epilepsy?
Adamec
J Psychopharmacol 1991;5:96-104.
ABSTRACT  

The effects of corticotrophin releasing factor (CRF) and handling stress on behavior in the elevated plus-maze test of anxiety
Adamec et al.
J Psychopharmacol 1991;5:175-186.
ABSTRACT  

Corticotropin-releasing factor immunoreactivity in post-mortem brain from depressed suicides
Charlton et al.
J Psychopharmacol 1988;2:13-18.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.